Christine Sorenson, PhD

Education

BS, Nuclear Medicine, University of Wisconsin–La Crosse, La Crosse, Wisconsin 
Other Training, Nuclear Medicine, Mayo Clinic, Rochester, Minnesota 
PhD, Biochemistry, University of Nebraska Medical Center, Omaha, Nebraska 
Postdoctoral Fellow, RNA Stability, McArdle Laboratory for Cancer Research, University of Wisconsin, Madison, Wisconsin 

Professional Activities

Dr. Christine Sorenson is distinguished scientist in the Division of Neonatology and Newborn Nursery. She has been very active at the University of Wisconsin working with undergraduate and graduate fellows on their research projects in the laboratory. This has allowed these students, many of whom have pursued careers in medicine, to gain a unique perspective on their field of study. Sorenson is also active in Biomedical Research Model Services (BRMS) on campus and interacts with other vision scientists locally and at national meetings. 

Research Interests

Sorenson’s laboratory studies the apoptotic and non-apoptotic roles Bcl-2 family members play during developmental and pathologic vascularization, particularly in the eye. Her lab uses transgenic mouse models for preclinical studies representing many human eye diseases. The Sorenson Research Group has a major interest in the interplay between macrophages and vascular cells associated with neovascularization and their influence on tissue remodeling and scar formation. Sorenson’s research goal is to better address ocular diseases with pathologic neovascularization, not only by delineating novel treatment modalities, but also to predicate which patients will have the most appropriate response to treatment.